When a hematological malignancy is characterised by normal differentiation of cells of myeloid cell line, it is referred to as myeloproliferative.
Portable hemoglobinometers provide easy and convenient measurement of hematological variables, especially in areas where no clinic labs are available.
This condition frequently occurs in patients with hematological malignancies and cancer patients receiving anticancer drugs that cause bone marrow suppression.
The risk of second primary hematological malignancies does not outweigh the benefit of using lenalidomide in relapsed or refractory multiple myeloma.
Most fusion genes are found from hematological cancers, sarcomas, and prostate cancer.
Approximately 20% of cases are associated with malignancy, predominantly hematological, especially acute myelogenous leukemia.
Splenic infarction is also more common in hematological disorders with associated splenomegaly, such as the myeloproliferative disorders.
This was accompanied by the commercial demise of phenacetin, blamed as the cause of analgesic nephropathy and hematological toxicity.
